Healthcare - Drug Manufacturers - Specialty & Generic - NASDAQ - US
$ 117.44
-4.42 %
$ 11.9 B
Market Cap
31.32
P/E
Price Target
Average
37.60%
Revenue Forecast
Estimate
20.98%
EBIT
Estimate
38.77%
Net Income
Estimate
51.59%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets
Neurocrine Biosciences, Inc.
Wall Street analysts predict an average 1-year price target for NBIX of $162 , with forecasts ranging from a low of $121 to a high of $200 .
NBIX Lowest Price Target
Wall Street Target
121 USD
3.03%
NBIX Average Price Target
Wall Street Target
162 USD
37.60%
NBIX Highest Price Target
Wall Street Target
200 USD
70.30%
REVENUE FORECAST
Revenue Forecast Chart NBIX
EBIT FORECAST
EBIT Forecast Chart NBIX
NET INCOME FORECAST
Net Income Chart NBIX